Application 205930
- Type
- ANDA
- Sponsor
- LUPIN LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PRASUGREL HYDROCHLORIDE | PRASUGREL | TABLET;ORAL | EQ 5MG BASE | No | No |
| 002 | PRASUGREL HYDROCHLORIDE | PRASUGREL | TABLET;ORAL | EQ 10MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205930-001 | PRASUGREL | PRASUGREL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2023-01-09 | ||
| A205930-002 | PRASUGREL | PRASUGREL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2023-01-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A205930-001 | PRASUGREL | EQ 5MG BASE | TABLET / ORAL | 2023-01-09 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A205930-002 | PRASUGREL | EQ 10MG BASE | TABLET / ORAL | 2023-01-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A205930-001 | PRASUGREL | EQ 5MG BASE | TABLET / ORAL | 2023-01-09 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A205930-002 | PRASUGREL | EQ 10MG BASE | TABLET / ORAL | 2023-01-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A205930-001 | PRASUGREL | EQ 5MG BASE | TABLET / ORAL | 2023-01-09 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A205930-002 | PRASUGREL | EQ 10MG BASE | TABLET / ORAL | 2023-01-09 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A205930-001 | PRASUGREL | EQ 5MG BASE | TABLET / ORAL | 2023-01-09 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A205930-002 | PRASUGREL | EQ 10MG BASE | TABLET / ORAL | 2023-01-09 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A205930-001 | PRASUGREL | EQ 5MG BASE | TABLET / ORAL | 2023-01-09 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A205930-002 | PRASUGREL | EQ 10MG BASE | TABLET / ORAL | 2023-01-09 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A205930-001 | PRASUGREL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2023-01-09 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | A205930-002 | PRASUGREL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2023-01-09 | 3bdfa0b2c4d7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A205930-001 | PRASUGREL | EQ 5MG BASE | TABLET / ORAL | 2023-01-09 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A205930-002 | PRASUGREL | EQ 10MG BASE | TABLET / ORAL | 2023-01-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-01-26 05:58 UTC | 2023-01 | A205930-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A205930-002 | AB | 1 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PRASUGREL | PRASUGREL | Apotex Corp. | f51e64e0-f556-65d0-a876-fb709aaeefea | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | American Health Packaging | 35aa7f3e-bbd8-4eae-b61f-29d1abca2224 | 2025-03-02 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| PRASUGREL | PRASUGREL | Panacea Biotec Limited | 944c195a-de24-a44c-8baa-84b624b5ddcb | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | Bryant Ranch Prepack | 9c3994da-da45-43ce-9727-a842a43c5693 | 2024-11-25 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | Golden State Medical Supply, Inc. | bb78f952-69a5-1620-e053-2a95a90afe97 | 2024-08-20 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | Aurobindo Pharma Limited | 596c923d-db8d-4b96-bf31-52186a38c30d | 2024-01-31 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | Accord Healthcare Inc. | cd6bf899-06b7-4f52-96c5-ffc94a7288ff | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | Unichem Pharmaceuticals (USA), Inc. | 5edc1ab3-5c7a-47d6-8aaa-00523c9b4c8f | 2023-08-31 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | Mylan Pharmaceuticals Inc. | 41a4e332-6725-4cb7-940a-8291cf56cfe4 | 2022-06-29 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
| Prasugrel | PRASUGREL | Amneal Pharmaceuticals LLC | 406cc201-89b6-43cc-9e14-a59327a5b4d8 | 2022-03-09 | Boxed warning, Warnings, Adverse reactions | PRASUGREL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.